EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Model-guided design of lymphatic drug delivery systems using osmotic pressure, viscosity and lymph node size

Reito Miyazaki, Ariunbuyan Sukhbaatar, Shiro Mori, Takahiro Kusaka, Katsunori Katagiri, Kiyoto Shiga, Tetsuya Kodama

Journal of Controlled Release · 2026-07 · 395 · 115010

DOI: 10.1016/j.jconrel.2026.115010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2026-07. Verfasst von Reito Miyazaki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Biomedical Engineering, Tohoku University, 4-1 Seiryo, Aoba Ward, Sendai 980-8575, Japan. Hauptthemen laut MEDLINE: Drug Delivery Systems, Lymph Nodes, Models, Biological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Keirin Autorace Foundation, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastatic lymph nodes (LNs) represent a major barrier to effective drug delivery in cancer therapy. To address this challenge, a lymphatic drug delivery system (LDDS) enabling direct intranodal administration has been developed. In LDDS, drug transport and retention are governed by formulation osmotic pressure and viscosity; however, optimization strategies according to LN size and therapeutic objectives remain unclear. Here, we established a quantitative framework that integrates mathematical modeling with machine and deep learning to describe and predict intranodal drug kinetics as a function of osmotic pressure, viscosity and Maximum cross-sectional area of LN (MALN). Using a unique mouse model possessing human-sized LNs, we first constructed a parametric model that accurately reproduced fluorescence intensity profiles in LNs. The model captured key kinetic features and is enabled to apply time-series datasets. A multilayer perceptron-based surrogate model was then trained to predict C(t) profiles and pharmacokinetic parameters across the entire π-μ-MALN space. In parallel, downstream LN transport exhibited two distinct Tmax phenotypes, which were successfully classified using machine learning to evaluate network-level delivery efficiency. Importantly, comparison with clinical LDDS data demonstrated that the model also describes early drug kinetics in human LNs. Because this framework relies only on clinically accessible LN size information, it enables inverse design of osmotic pressure and viscosity tailored to LN size and desired delivery outcomes. This study provides a mechanistically grounded and translatable strategy for rational LDDS formulation design to support controlled lymphatic drug delivery in future clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Delivery SystemsLymph NodesModels, BiologicalAnimalsViscosityOsmotic PressureHumansFemaleMachine Learning

Stichwörter der Autor:innen

Deep learningLymphatic drug delivery system (LDDS)Machine learningMathematical modelOsmotic pressureViscosity

Autor:innen und Institutionen

  • Graduate School of Biomedical Engineering, Tohoku University, 4-1 Seiryo, Aoba Ward, Sendai 980-8575, Japan.
  • Graduate School of Biomedical Engineering, Tohoku University, 4-1 Seiryo, Aoba Ward, Sendai 980-8575, Japan; Graduate School of Dentistry, Tohoku University, 4-1 Seiryo, Aoba Ward, Sendai 980-8575, Japan; Biomedical Eng…
  • Department of Head and Neck Surgery, Iwate Medical University School of Medicine, 2-1-1 Idai-dori, Yahaba-cho, Shiwa-gun, 028-3695, Japan.
  • Graduate School of Biomedical Engineering, Tohoku University, 4-1 Seiryo, Aoba Ward, Sendai 980-8575, Japan; Biomedical Engineering Cancer Research Center, Graduate School of Biomedical Engineering, Tohoku University, 4…

Förderung

  • Japan Keirin Autorace Foundation
  • Japan Society for the Promotion of Science

Zitieren

APA

Miyazaki, R., Sukhbaatar, A., Mori, S., Kusaka, T., Katagiri, K., Shiga, K., & Kodama, T. (2026). Model-guided design of lymphatic drug delivery systems using osmotic pressure, viscosity and lymph node size. Journal of Controlled Release, 395, 115010. https://doi.org/10.1016/j.jconrel.2026.115010

Vancouver

Miyazaki R, Sukhbaatar A, Mori S, Kusaka T, Katagiri K, Shiga K, et al. Model-guided design of lymphatic drug delivery systems using osmotic pressure, viscosity and lymph node size. Journal of Controlled Release. 2026;395:115010. doi:10.1016/j.jconrel.2026.115010

BibTeX
@article{Miyazaki2026,
  author = {Miyazaki, Reito and Sukhbaatar, Ariunbuyan and Mori, Shiro and Kusaka, Takahiro and Katagiri, Katsunori and Shiga, Kiyoto and Kodama, Tetsuya},
  title = {Model-guided design of lymphatic drug delivery systems using osmotic pressure, viscosity and lymph node size},
  journal = {Journal of Controlled Release},
  year = {2026},
  volume = {395},
  pages = {115010},
  doi = {10.1016/j.jconrel.2026.115010}
}
Kostenlos starten →